World Anti-Doping Agency (WADA) IGFDES falls under WADAs prohibited substances list under Peptide Hormones, Growth Factors, and Related Substances (S2 category)
Here for You: Do you test your products and provide COAs
(8) Synergistic Action of Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend The rationale for combining these peptides lies in their supposed distinct mechanisms of action and potential to enhance growth hormone (GH) secretion synergistically
CJC-1295 (NO DAC) + Ipamorelin Peptide Blend Research & Scientific Overview Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References CJC-1295 (NO DAC) + Ipamorelin Peptide Blend Molecular Structure & Chemical Properties The CJC-1295 (NO DAC) + Ipamorelin peptide blend represents one of the most extensively studied growth hormone secretagogue combinations in preclinical research, with investigations spanning over two decades examining their synergistic effects on pituitary growth hormone release
It Helps Personalize Peptide or Hormone Protocols In patients using peptides like Sermorelin, CJC-1295, or Ipamorelin, we track both IGF-1 and IGFBP-3 to assess response
Nanotechnology provides new methods for oral delivery of peptides
